Abstract
Last decade has witnessed the revival of interest in peptides as potential therapeutics candidates. However, one of the bottlenecks in the success of therapeutic peptides in clinics is their toxicity towards eukaryotic cells. Therefore, considerable efforts have been made over the years both in wet and dry lab to overcome this limitation. With the advances in peptide synthesis, now it is possible to fine-tune the physicochemical properties of peptides by incorporating several chemical modifications and thus to optimize the peptide functionality in order to minimize the toxicity without compromising their therapeutic activity. Also various in silico tools for peptide toxicity prediction and peptide designing have been developed, which facilitates designing of therapeutic peptides with desired toxicity. In this chapter, we have discussed both wet lab and dry lab approaches used to optimize peptide toxicity. More emphasis has been given to describe the in silico method, ToxinPred, to predict the toxicity of peptide and about how to design a peptide or protein with desired toxicity by mutating minimum number of amino acids.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Thundimadathil J (2012) Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012:967347
Saladin PM, Zhang BD, Reichert JM (2009) Current trends in the clinical development of peptide therapeutics. IDrugs 12:779–784
Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15:40–56
Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81:136–147
Descotes J (2006) Methods of evaluating immunotoxicity. Expert Opin Drug Metab Toxicol 2:249–259
Dhanda SK, Gupta S, Vir P, Raghava GPS (2013) Prediction of IL4 inducing peptides. Clin Dev Immunol. doi:10.1155/2013/263952
Nielsen M, Lund O, Buus S, Lundegaard C (2010) MHC class II epitope predictive algorithms. Immunology 130:319–328
Singh H, Raghava GP (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236–1237
Gupta S, Ansari HR, Gautam A, Raghava GP (2013) Identification of B-cell epitopes in an antigen for inducing specific class of antibodies. Biol Direct 8:27
Dhanda SK, Vir P, Raghava GPS (2013) Designing of interferon-gamma inducing MHC class-II binders. Biol Direct 8:30
Goodwin D, Simerska P, Toth I (2012) Peptides as therapeutics with enhanced bioactivity. Curr Med Chem 19:4451–4461
Uchide N, Ohyama K, Bessho T, Toyoda H (2009) Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells. Intervirology 52:164–173
Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160:171–177
Cree IA, Andreotti PE (1997) Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicol In Vitro 11:553–556
Kalcheim C, Goldstein RS (1991) Segmentation of sensory and sympathetic ganglia: interactions between neural crest and somite cells. J Physiol Paris 85:110–116
Kondejewski LH, Jelokhani-Niaraki M, Farmer SW, Lix B, Kay CM, Sykes BD, Hancock RE, Hodges RS (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J Biol Chem 274:13181–13192
Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, Drijfhout JW, Grote JJ (2006) Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27:649–660
Albada HB, Prochnow P, Bobersky S, Langklotz S, Bandow JE, Metzler-Nolte N (2013) Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues. ACS Comb Sci 15:585–592
Veronese FM, Harris JM (2002) Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 54:453–456
Fox MA, Thwaite JE, Ulaeto DO, Atkins TP, Atkins HS (2012) Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II. Peptides 33:197–205
Morris CJ, Beck K, Fox MA, Ulaeto D, Clark GC, Gumbleton M (2012) Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. Antimicrob Agents Chemother 56:3298–3308
He Q, Han W, He Q, Huo L, Zhang J, Lin Y, Chen P, Liang S (2010) ATDB 2.0: a database integrated toxin-ion channel interaction data. Toxicon. doi:10.1016/j.toxicon.2010.05.013
Chen L, Xiong Z, Sun L, Yang J, Jin Q (2012) VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40:D641–D645
Chakraborty A, Ghosh S, Chowdhary G, Maulik U, Chakrabarti S (2012) DBETH: a database of bacterial exotoxins for human. Nucleic Acids Res 40:D615–D620
Kaas Q, Yu R, Jin A-H, Dutertre S, Craik DJ (2012) ConoServer: updated content, knowledge, and discovery tools in the conopeptide database. Nucleic Acids Res 40:D325–D330
Apweiler R, Bairoch A, Wu CH et al (2004) UniProt: the Universal Protein knowledgebase. Nucleic Acids Res 32:D115–D119
Naamati G, Askenazi M, Linial M (2009) ClanTox: a classifier of short animal toxins. Nucleic Acids Res 37:W363–W368
Saha S, Raghava GPS (2007) BTXpred: prediction of bacterial toxins. In Silico Biol 7:405–412
Saha S, Raghava GPS (2007) Prediction of neurotoxins based on their function and source. In Silico Biol 7:369–387
Saha S, Raghava GPS (2006) VICMpred: an SVM-based method for the prediction of functional proteins of Gram-negative bacteria using amino acid patterns and composition. Genomics Proteomics Bioinformatics 4:42–47
Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GPS (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS One 8:e73957
Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li WW, Noble WS (2009) MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37:W202–W208
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Raghava, G.P.S. (2015). Peptide Toxicity Prediction. In: Zhou, P., Huang, J. (eds) Computational Peptidology. Methods in Molecular Biology, vol 1268. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2285-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2285-7_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2284-0
Online ISBN: 978-1-4939-2285-7
eBook Packages: Springer Protocols